Literature DB >> 8573587

Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.

E Hamel1, C M Lin, E Flynn, R J D'Amato.   

Abstract

2-Methoxyestradiol (2ME) is an endogenous mammalian catabolite of estradiol with antimitotic activity. Although it is a competitive inhibitor of the binding of colchicine to tubulin, it has unusual effects on glutamate-induced tubulin polymerization. Polymer that was little changed in morphology assembled at a reduced rate and was relatively cold stable. We have now examined interactions of [4-3H]-2ME with unpolymerized tubulin and polymer. The [3H]2ME binds avidly to tubulin even on ice, and it is readily displaced by other colchicine site drugs. An association rate constant on ice of 1.9 x 10(2) M-1s-1 was obtained. Scatchard analysis indicated a single class of binding site and an association equilibrium constant of 5.7 x 10(5) M-1. These values lead to a calculated dissociation rate constant of 3.3 x 10(-4) s-1. In glutamate-induced tubulin assembly, a reaction that requires GTP and leads to the formation of sheets of parallel protofilaments, increasing amounts of [3H]2ME were incorporated into polymer, reaching near-stoichiometry with tubulin at 100 microM 2ME. Equivalent binding of [3H]2ME occurred when the drug was added to preformed polymer, but binding of [3H]2ME to polymer was not readily inhibited by colchicine site drugs. Significant amounts of [3H]2ME were also incorporated into microtubule polymer formed with microtubule-associated proteins, glycerol, or 4-morpholineethanesulfonate buffer, but the stoichiometry was substantially lower than that in the sheet polymer induced by either glutamate or 1,4-piperazineethanesulfonate buffer. The structural differences between the microtubule and sheet polymers leading to these differences in apparent affinity for 2ME are unknown, but presumably interaction of the estrogen metabolite with cellular microtubules has functional significance related to the antimitotic properties of the compound.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573587     DOI: 10.1021/bi951559s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Structure based drug design and in vitro metabolism study: Discovery of N-(4-methylthiophenyl)-N,2-dimethyl-cyclopenta[d]pyrimidine as a potent microtubule targeting agent.

Authors:  Weiguo Xiang; Shruti Choudhary; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2018-04-04       Impact factor: 3.641

Review 2.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

3.  Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F]fluoroethoxyestradiol for positron emission tomography.

Authors:  Jiyoung Mun; Yuefang Wang; Ronald J Voll; Daniel Escuin-Borras; Paraskevi Giannakakou; Mark M Goodman
Journal:  Nucl Med Biol       Date:  2008-07       Impact factor: 2.408

4.  Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly.

Authors:  K Murakami; A Fellous; E E Baulieu; P Robel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

5.  Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton.

Authors:  K Chamaon; J Stojek; D Kanakis; S Braeuninger; E Kirches; G Krause; C Mawrin; K Dietzmann
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

6.  Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents.

Authors:  Rajendra P Tanpure; Amanda R Harkrider; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2009-08-12       Impact factor: 3.641

7.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

8.  Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules.

Authors:  Nava Dalyot-Herman; Fernando Delgado-Lopez; David A Gewirtz; John T Gupton; Edward L Schwartz
Journal:  Biochem Pharmacol       Date:  2009-07-01       Impact factor: 5.858

Review 9.  Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer.

Authors:  William D Figg; Erwin A Kruger; Douglas K Price; Sonia Kim; William D Dahut
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

10.  Improved survival of mice bearing liver metastases of colon cancer cells treated with a combination of radioimmunotherapy and antiangiogenic therapy.

Authors:  Seigo Kinuya; Kunihiko Yokoyama; Kiyoshi Koshida; Hirofumi Mori; Kazuhiro Shiba; Naoto Watanabe; Noriyuki Shuke; Jingming Bai; Takatoshi Michigishi; Norihisa Tonami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.